HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Kendall Capital Management

Kendall Capital Management trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,460 shares of the company’s stock after selling 195 shares during the quarter. Kendall Capital Management’s holdings in HCA Healthcare were worth $1,339,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Legacy Investment Solutions LLC bought a new position in HCA Healthcare in the 3rd quarter worth approximately $39,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the 3rd quarter worth approximately $41,000. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the 4th quarter worth approximately $31,000. Activest Wealth Management boosted its stake in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. boosted its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HCA. Morgan Stanley decreased their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Truist Financial decreased their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, KeyCorp cut their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $330.11 on Friday. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The business has a fifty day simple moving average of $316.70 and a 200 day simple moving average of $347.49. The firm has a market cap of $81.27 billion, a price-to-earnings ratio of 15.03, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business earned $5.90 earnings per share. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.87%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.